OLGC Orthologic (MM)

TEMPE, Ariz., Oct. 18 /PRNewswire-FirstCall/ -- OrthoLogic Corp. (NASDAQ:OLGC) announced today that it will release financial and operating results for the third quarter of 2005 on Tuesday, October 25, 2005 after the U.S. markets close. Management will host a conference call and webcast the same day at 4:30 p.m. EDT (1:30 p.m. PDT). To access the call, participants may dial 800-946-0706 (domestic) or 719-457-2638 (international) and provide the access code 6958949. A replay of the call will be available beginning October 25, 2005, at 7:30 p.m. EDT until November 23, 2005, at 12:59 a.m. EST. To access the replay, please dial 888-203-1112 (domestic) or 719-457-0820 (international) and provide the access code 6958949. Additionally, the conference call will be webcast on the Investors section of the Company's website, http://www.orthologic.com/. About OrthoLogic OrthoLogic is a biotechnology company focused on the development and commercialization of the novel synthetic peptide Chrysalin(R) (TP508) in three lead indications, all of which represent areas of significant unmet medical need -- fracture repair, diabetic foot ulcer healing and cartilage defect repair. Based on the Company's pioneering scientific research of the natural healing cascade, OrthoLogic has become the leading company focused on tissue and bone repair. OrthoLogic is committed to developing a pipeline of novel peptides and other molecules aimed at helping patients with equally under-served conditions. The Company maintains exclusive worldwide rights for Chrysalin. OrthoLogic's corporate headquarters are in Tempe, Arizona. For more information, please visit the company's website: http://www.orthologic.com/. DATASOURCE: OrthoLogic Corp. CONTACT: Sherry A. Sturman, Chief Financial Officer of OrthoLogic Corp., +1-602-286-5436; or Melanie Friedman of Stern Investor Relations, Inc., +1-212-362-1200, for OrthoLogic Corp. Web site: http://www.orthologic.com/

Copyright